Physician profile
Jonathan S Levine
NPI 1548283393
$2,871.79
in general payments reported to CMS, 2019-2025
17 companies · $807 in 2025
The $807 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.51 · 2020: $187 · 2021: $101 · 2022: $589 · 2023: $286 · 2024: $881 · 2025: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,837 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,836.90 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $373.11 | 2020-2023 | Iovera |
| Medical Device Business Services, INC. | $363.45 | 2024 | |
| Stryker Corporation | $327.34 | 2022-2025 | Spy-Phi System |
| Kerecis Limited | $250.00 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Intuitive Surgical, INC. | $219.25 | 2020-2024 | |
| Atricure, INC. | $165.83 | 2024 | |
| Davol INC. | $164.65 | 2023-2024 | Phasix Mesh |
| Solventum Corporation | $153.28 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Tela Bio, INC. | $150.81 | 2022 | |
| Aroa Biosurgery Incorporated | $137.99 | 2023 | |
| Eagle Pharmaceuticals, INC. | $127.51 | 2024 | |
| Csl Behring | $125.00 | 2025 | Kcentra |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.24 | 2025 | Gattex |
| Bard Peripheral Vascular, INC. | $30.00 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Focal Therapeutics, INC. | $20.51 | 2019 | |
| Smith+Nephew, INC. | $19.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.